{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:58:05Z","timestamp":1753891085008,"version":"3.41.2"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Kaposi\u2019s Sarcoma (KS) is a neoplasm derived from endothelial cells and is associated with human herpesvirus-8 (HHV-8) infection. It is mostly seen in patients suffering from AIDS and\/or chronic immunosuppression. Currently, systemic chemotherapy is the primary treatment option for the advanced KS. However, there is no consensus on the treatment of KS. In this case, an 84-year-old man with a history of psoriasis developed multiple painful dark purple nodules on the trunk and extremities during the treatment of drug reaction with eosinophilia and systemic symptoms (DRESS). KS was confirmed by the skin biopsy, and the immunohistochemical staining demonstrated the positivity for HHV-8 while the anti-HIV test was negative. The patient then received anlotinib treatment, a tyrosine kinase inhibitor, for 5 months, and his skin lesions subsided. This case indicates that anlotinib may be a potential treatment option for KS.<\/jats:p>","DOI":"10.3389\/fmed.2022.907345","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T04:59:16Z","timestamp":1653454756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Successful Treatment of Kaposi\u2019s Sarcoma With Anlotinib in an HIV-Negative Patient After the Treatment of Drug Reaction With Eosinophilia and Systemic Symptoms Accessory Tragus"],"prefix":"10.3389","volume":"9","author":[{"given":"Min","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/bf01830024","article-title":"Idiopathisches multiples pigmentsarkom der ttaut.","volume":"4","author":"Kaposi","year":"1872","journal-title":"Arch Dermatol Syphilis."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/11795549211067184","article-title":"Effectiveness and safety of anlotinib monotherapy for patients with extensive-stage small-cell lung cancer who progressed to chemotherapy: a real-world exploratory study.","volume":"16","author":"Li","year":"2022","journal-title":"Clin Med Insights Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1089\/thy.2021.0307","article-title":"The efficacy and safety of anlotinib in neoadjuvant treatment of locally advanced thyroid cancer: a single-arm phase Ii clinical trial.","volume":"31","author":"Huang","year":"2021","journal-title":"Thyroid."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.664853","article-title":"Anlotinib: a novel targeted drug for bone and soft tissue sarcoma.","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3760\/cma.j.cn112152-20200214-00089","article-title":"[Long term follow-up results of anlotinib in the treatment of advanced renal cell carcinoma].","volume":"42","author":"Song","year":"2020","journal-title":"Zhonghua zhong liu za zhi."},{"key":"B6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejca.2018.12.036","article-title":"Diagnosis and treatment of Kaposi\u2019s sarcoma: European consensus-based interdisciplinary guideline (EDF\/EADO\/EORTC).","volume":"114","author":"Lebbe","year":"2019","journal-title":"Eur J Cancer."},{"key":"B7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019.","volume":"68","author":"Shiohara","year":"2019","journal-title":"Allergol Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5858\/arpa.2012-0101-RS","article-title":"Kaposi sarcoma.","volume":"137","author":"Radu","year":"2013","journal-title":"Arch Pathol Lab Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3857\/roj.2020.00885","article-title":"Palliative treatment of Kaposi sarcoma with radiotherapy: a single center experience.","volume":"39","author":"Inan","year":"2021","journal-title":"Radiat Oncol J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1365-2133.2009.09601.x","article-title":"Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients.","volume":"162","author":"Brambilla","year":"2010","journal-title":"Br J Dermatol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2021.2226","article-title":"Electrochemotherapy in Kaposi sarcoma: a systematic review.","volume":"14","author":"Ferioli","year":"2021","journal-title":"Mol Clin Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2165\/00128071-200102020-00004","article-title":"Phase Iii vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous aids-related Kaposi\u2019s sarcoma.","volume":"2","author":"Bodsworth","year":"2001","journal-title":"Am J Clin Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/DDDT.S28997","article-title":"Update on taxane development: new analogs and new formulations.","volume":"6","author":"Yared","year":"2012","journal-title":"Drug Des Devel Ther."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09050-6","article-title":"Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: a real-world study.","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cancer."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00102","article-title":"KSHV induction of angiogenic and lymphangiogenic phenotypes.","volume":"3","author":"Dimaio","year":"2012","journal-title":"Front Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1158\/1078-0432.CCR-18-3528","article-title":"A pilot study of liposomal doxorubicin combined with bevacizumab followed by bevacizumab monotherapy in patients with advanced Kaposi sarcoma.","volume":"25","author":"Ramaswami","year":"2019","journal-title":"Clin Cancer Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1200\/JCO.2012.48.6365","article-title":"Phase Ii trial of imatinib in aids-associated kaposi\u2019s sarcoma: aids malignancy consortium protocol 042.","volume":"32","author":"Koon","year":"2014","journal-title":"J Clin Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/ijc.32180","article-title":"Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of vegfr2 and met in osteosarcoma.","volume":"145","author":"Wang","year":"2019","journal-title":"Int J Cancer."},{"key":"B19","first-page":"1851","article-title":"Vascular endothelial growth factor regulates.","volume":"149","author":"Cornali","year":"1996","journal-title":"Am J Pathol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.907345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T04:59:21Z","timestamp":1653454761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.907345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":19,"alternative-id":["10.3389\/fmed.2022.907345"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.907345","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"article-number":"907345"}}